Everstar Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-199
Closed -$214K 207
2025
Q4
$214K Sell
199
-86
-30% -$82.2K 0.11% 169
2025
Q3
$217K Buy
+285
New +$212K 0.12% 166
2024
Q4
Sell
-251
Closed -$222K 194
2024
Q3
$222K Buy
+251
New +$226K 0.15% 162

Other funds holding LLY

Everstar Asset Management's LLY Position: Q1 2026 in Review

Everstar Asset Management sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 199 shares — an estimated $214K sold.

Everstar Asset Management first reported a position in LLY in Q3 2024 and held it in 3 quarters. The position peaked at $222K in Q3 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Everstar Asset Management reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
  • Everstar Asset Management sold 199 Eli Lilly shares in Q1 2026, an estimated $214K.
  • Everstar Asset Management first reported a position in Eli Lilly in Q3 2024 and held it in 3 quarters.
  • Everstar Asset Management's Eli Lilly position peaked at $222K in Q3 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Everstar Asset Management's 13F filing for Q1 2026, filed 16 Apr 2026.